{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:07:44Z","timestamp":1784603264625,"version":"3.55.0"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.3760","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T15:30:53Z","timestamp":1587742253000},"page":"e203760","source":"Crossref","is-referenced-by-count":29,"title":["Association of Nongenetic Factors With Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort"],"prefix":"10.1001","volume":"3","author":[{"given":"Kawthar","family":"Al Ajmi","sequence":"first","affiliation":[{"name":"Division of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, Centre for Epidemiology, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artitaya","family":"Lophatananon","sequence":"additional","affiliation":[{"name":"Division of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, Centre for Epidemiology, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Mekli","sequence":"additional","affiliation":[{"name":"Cathie Marsh Institute for Social Research, School of Social Sciences, Faculty of Humanities, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Ollier","sequence":"additional","affiliation":[{"name":"Division of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, Centre for Epidemiology, University of Manchester, Manchester, United Kingdom"},{"name":"School of Healthcare Science, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Muir","sequence":"additional","affiliation":[{"name":"Division of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, Centre for Epidemiology, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"issue":"7261","key":"zoi200176r1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","article-title":"ABC of breast diseases: breast cancer-epidemiology, risk factors, and genetics.","volume":"321","author":"McPherson","year":"2000","journal-title":"BMJ"},{"issue":"5","key":"zoi200176r3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/87876","article-title":"Breast cancer genetics: what we know and what we need.","volume":"7","author":"Nathanson","year":"2001","journal-title":"Nat Med"},{"issue":"2","key":"zoi200176r4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2.","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"issue":"1","key":"zoi200176r5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic risk scores for prediction of breast cancer and breast cancer subtypes.","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"10","key":"zoi200176r6","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/bjc.2011.118","article-title":"Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.","volume":"104","author":"Pashayan","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"zoi200176r7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ng853","article-title":"Polygenic susceptibility to breast cancer and implications for prevention.","volume":"31","author":"Pharoah","year":"2002","journal-title":"Nat Genet"},{"issue":"5","key":"zoi200176r8","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv036","article-title":"Prediction of breast cancer risk based on profiling with common genetic variants.","volume":"107","author":"Mavaddat","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"zoi200176r9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201097","article-title":"Risk of breast cancer in the UK Biobank female cohort and its relationship to anthropometric and reproductive factors.","volume":"13","author":"Al-Ajmi","year":"2018","journal-title":"PLoS One"},{"issue":"9382","key":"zoi200176r10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study.","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"zoi200176r11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jnci\/djq527","article-title":"Breast cancer risk in relation to the interval between menopause and starting hormone therapy.","volume":"103","author":"Beral","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"zoi200176r12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1023\/A:1008984432272","article-title":"Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index, Risk Index Working Group, Harvard Center for Cancer Prevention.","volume":"11","author":"Colditz","year":"2000","journal-title":"Cancer Causes Control"},{"key":"zoi200176r13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3332\/ecancer.2018.792","article-title":"Healthy living and cancer: evidence from UK Biobank.","volume":"12","author":"Elwood","year":"2018","journal-title":"Ecancermedicalscience"},{"issue":"11","key":"zoi200176r14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/sj.bjc.6600596","article-title":"Alcohol, tobacco and breast cancer\u2014collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease.","volume":"87","author":"Hamajima","year":"2002","journal-title":"Br J Cancer"},{"issue":"24","key":"zoi200176r16","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease.","volume":"375","author":"Khera","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi200176r17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jama.2019.9879","article-title":"Association of lifestyle and genetic risk with incidence of dementia.","volume":"322","author":"Lourida","year":"2019","journal-title":"JAMA"},{"issue":"10","key":"zoi200176r23","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/ijc.29987","article-title":"Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: estimates from the E3N-EPIC cohort.","volume":"138","author":"Dartois","year":"2016","journal-title":"Int J Cancer"},{"issue":"9316","key":"zoi200176r24","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","article-title":"Outcome of conservatively managed early-onset breast cancer by BRCA1\/2 status.","volume":"359","author":"Haffty","year":"2002","journal-title":"Lancet"},{"issue":"8852","key":"zoi200176r25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/0140-6736(93)92407-K","article-title":"Age as prognostic factor in premenopausal breast carcinoma.","volume":"341","author":"de la Rochefordi\u00e8re","year":"1993","journal-title":"Lancet"},{"issue":"11","key":"zoi200176r26","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1038\/bjc.1996.632","article-title":"Breast carcinomas occurring in young women (< 35 years) are different.","volume":"74","author":"Walker","year":"1996","journal-title":"Br J Cancer"},{"issue":"3","key":"zoi200176r27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.molonc.2010.04.011","article-title":"Genetic susceptibility to breast cancer.","volume":"4","author":"Mavaddat","year":"2010","journal-title":"Mol Oncol"},{"issue":"49","key":"zoi200176r28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/jncimonographs\/lgu019","article-title":"Adolescent and young adult cancer survival.","volume":"2014","author":"Lewis","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"10","key":"zoi200176r29","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s10552-018-1072-6","article-title":"Review of non-clinical risk models to aid prevention of breast cancer.","volume":"29","author":"Al-Ajmi","year":"2018","journal-title":"Cancer Causes Control"},{"issue":"1","key":"zoi200176r30","doi-asserted-by":"crossref","DOI":"10.2427\/12853","article-title":"The epidemiology of breast cancer, a summary overview.","volume":"15","author":"La Vecchia","year":"2018","journal-title":"Epidemiol Biostat Public Health"},{"issue":"1","key":"zoi200176r31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/jcmm.2005.9.issue-1","article-title":"Understanding breast cancer risk\u2014where do we stand in 2005?","volume":"9","author":"Dumitrescu","year":"2005","journal-title":"J Cell Mol Med"},{"issue":"1-2","key":"zoi200176r32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.maturitas.2008.11.016","article-title":"Breast cancer: hormones and other risk factors.","volume":"61","author":"Hulka","year":"2008","journal-title":"Maturitas"},{"issue":"5","key":"zoi200176r33","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/ijc.31394","article-title":"Adiposity and breast cancer risk in postmenopausal women: results from the UK Biobank prospective cohort.","volume":"143","author":"Guo","year":"2018","journal-title":"Int J Cancer"},{"issue":"4","key":"zoi200176r34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"zoi200176r35","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/(ISSN)1097-0215","article-title":"Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study.","volume":"105","author":"Dumeaux","year":"2003","journal-title":"Int J Cancer"},{"issue":"11","key":"zoi200176r36","first-page":"1375","article-title":"Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women\u2019s Lifestyle and Health Cohort Study.","volume":"11","author":"Kumle","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9017","key":"zoi200176r37","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"zoi200176r38","first-page":"437","article-title":"Treatment with human chorionic gonadotropin and risk of breast cancer.","volume":"4","author":"Bernstein","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"zoi200176r18","author":"Bycroft","year":"2017"},{"key":"zoi200176r2","unstructured":"Cancer Research UK. Breast cancer statistics. Accessed April 5, 2019. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer#heading-Four"},{"key":"zoi200176r15","unstructured":"Cancer Research UK. Risk factors 2017. Accessed March 26, 2020. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer\/risk-factors"},{"key":"zoi200176r19","unstructured":"Chang? C. PLINK 1.90 beta. Updated 2019. Accessed June 28, 2019. https:\/\/www.cog-genomics.org\/plink2"},{"key":"zoi200176r20","unstructured":"Stata.com. Ltable\u2014life tables for survival data. Accessed May 5, 2019. https:\/\/www.stata.com\/manuals13\/stltable.pdf"},{"key":"zoi200176r21","unstructured":"Microsoft. Microsoft Excel. Accessed July 24, 2019. https:\/\/products.office.com\/en-gb\/excel"},{"key":"zoi200176r22","unstructured":"StataCorp LLC. Stata\/MP. Accessed November 1, 2018. https:\/\/www.stata.com\/statamp\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2764845\/al_ajmi_2020_oi_200176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T08:49:46Z","timestamp":1696063786000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2764845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3760","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]}}}